366 related articles for article (PubMed ID: 8844209)
1. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
DeMarchi JM; Caskey CT; Richards CS
Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
[TBL] [Abstract][Full Text] [Related]
2. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
3. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
Strasberg PM; Clarke JT
Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
[TBL] [Abstract][Full Text] [Related]
4. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
[TBL] [Abstract][Full Text] [Related]
5. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
Myerowitz R; Costigan FC
J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
[TBL] [Abstract][Full Text] [Related]
6. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
Navon R; Proia RL
Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
Akerman BR; Natowicz MR; Kaback MM; Loyer M; Campeau E; Gravel RA
Am J Hum Genet; 1997 May; 60(5):1099-106. PubMed ID: 9150157
[TBL] [Abstract][Full Text] [Related]
8. Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.
Drucker L; Proia RL; Navon R
Am J Hum Genet; 1992 Aug; 51(2):371-7. PubMed ID: 1322637
[TBL] [Abstract][Full Text] [Related]
9. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
[TBL] [Abstract][Full Text] [Related]
10. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
[TBL] [Abstract][Full Text] [Related]
11. Distribution of three alpha-chain beta-hexosaminidase A mutations among Tay-Sachs carriers.
Grebner EE; Tomczak J
Am J Hum Genet; 1991 Mar; 48(3):604-7. PubMed ID: 1825595
[TBL] [Abstract][Full Text] [Related]
12. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
Rozenberg R; Pereira Lda V
Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
[TBL] [Abstract][Full Text] [Related]
13. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.
Bach G; Tomczak J; Risch N; Ekstein J
Am J Med Genet; 2001 Feb; 99(1):70-5. PubMed ID: 11170098
[TBL] [Abstract][Full Text] [Related]
14. A gel electrophoretic assay for detecting the insertion defect in Ashkenazi Jewish carriers of Tay-Sachs disease.
Shore S; Myerowitz R
Anal Biochem; 1990 Apr; 186(1):179-81. PubMed ID: 2356966
[TBL] [Abstract][Full Text] [Related]
15. Biochemistry and genetics of Tay-Sachs disease.
Gravel RA; Triggs-Raine BL; Mahuran DJ
Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
[TBL] [Abstract][Full Text] [Related]
16. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
17. Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.
Karpati M; Gazit E; Goldman B; Frisch A; Colombo R; Peleg L
Neurogenetics; 2004 Feb; 5(1):35-40. PubMed ID: 14648242
[TBL] [Abstract][Full Text] [Related]
18. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.
Paw BH; Tieu PT; Kaback MM; Lim J; Neufeld EF
Am J Hum Genet; 1990 Oct; 47(4):698-705. PubMed ID: 2220809
[TBL] [Abstract][Full Text] [Related]
19. Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutations causing Jewish Tay-Sachs disease.
Mahuran DJ
Clin Biochem; 1995 Apr; 28(2):101-6. PubMed ID: 7628066
[TBL] [Abstract][Full Text] [Related]
20. Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.
Schneider A; Nakagawa S; Keep R; Dorsainville D; Charrow J; Aleck K; Hoffman J; Minkoff S; Finegold D; Sun W; Spencer A; Lebow J; Zhan J; Apfelroth S; Schreiber-Agus N; Gross S
Am J Med Genet A; 2009 Nov; 149A(11):2444-7. PubMed ID: 19876898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
